Author Relationships With Industry and Other Entities (Relevant)—2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

Committee Member	Employment	Consultant	Speaker’s Bureau	Ownership/ Partnership/ Principal	Personal Research	Expert Witness
Michael D. Jensen, Co-Chair	Mayo Clinic	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None
	Endocrine Research Unit— Professor of Medicine, Endocrinology, Metabolism, Diabetes, Nutrition, and Internal Medicine Division	2013 Eisai Novo Nordisk Vivus	2013 None	2013 None	2013 None	2013 None
Donna H. Ryan, Co-Chair	Pennington Biomedical Research Center—Associate Executive Director for Clinical Research	2008–2012 Alere Wellbeing Amylin Arena Pharmaceuticals Eisai Novo Nordisk Nutrisystem Orexigen Takeda Vivus	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None
		2013 Arena Pharmaceuticals Eisai Novo Nordisk Takeda Vivus	2013 None	2013 Scientific Intake	2013 None	2013 None
Caroline M. Apovian	Boston Medical Center—Professor of Medicine and Pediatrics; Center for Nutrition and Weight Management— Director	2008–2012 Amylin Arena Pharmaceuticals Johnson & Johnson Merck Nutrisystem Orexigen Sanofi-aventis Zafgen	2008–2012 None	2008–2012 None	2008–2012 Amylin Dr. Robert C. and Veronica Atkins Foundation Eli Lilly MetaProteomics Orexegin Pfizer Sanofi-aventis	2008–2012 None
		2013 Abbott Nutrition Allergan Amylin Arena Pharmaceuticals GI Dynamics Johnson & Johnson Merck Novo Nordisk Nutrisystem Orexigen Therapeutics Pfizer Sanofi-aventis Zafgen	2013 None	2013 None	2013 Amylin† Aspire Bariatrics† Dr. Robert C. and Veronica Atkins Foundation† Eli Lilly† GI Dynamics† GlaxoSmithKline MetaProteomics Orexigen Therapeutics† Pfizer† Sanofi-aventis	2013 None
Jamy D. Ard	Wake Forest University— Assistant Professor of Epidemiology and Prevention; Weight Management Center—Co-Director	2008–2012 Arena Pharmaceuticals Nestle Healthcare Nutrition OPTIFAST Division Vivus	2008–2012 None	2008–2012 None	2008–2012 OPTIFAST—Medical Director	2008–2012 None
		2013 Eisai Nestle Healthcare Nutrition OPTIFAST Division Vivus	2013 None	2013 None	2013 None	2013 None
Anthony G. Comuzzie	Southwest Foundation for Biomedical Research—Scientist, Department of Genetics	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None
		2013 None	2013 None	2013 None	2013 None	2013 None
Karen A. Donato	NHLBI—Acting Director, Division for the Application of Research Discoveries	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None
		2013 None	2013 None	2013 None	2013 None	2013 None
Frank B. Hu	Harvard University School of Public Health—Professor, Nutrition and Epidemiology	2008–2012 Amgen Novo Nordisk Nutrition Impact Unilever	2008–2012 None	2008–2012 None	2008–2012 Merck	2008–2012 None
		2013 Bunge	2013 None	2013 None	2013 Merck	2013 None
Van S. Hubbard, Ex-Officio	NIDDK—Director, NIH Division of Nutrition Research Coordination	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None
		2013 None	2013 None	2013 None	2013 None	2013 None
John M. Jakicic	University of Pittsburgh—Professor and Chair, Physical Activity and Weight Management Research Center	2008–2012 Alere Wellbeing Jenny Craig Nestle Nutrition	2008–2012 None	2008–2012 None	2008–2012 BodyMedia—PI	2008–2012 None
		2013 Calorie Control Council	2013 None	2013 None	2013 BodyMedia—PI	2013 None
Robert F. Kushner	Northwestern University Feinberg School of Medicine—Professor, Division of General Internal Medicine	2008–2012 Abbott Amylin Novo Nordisk Orexigen Retrofit Sanofi-aventis Zafgen	2008–2012 None	2008–2012 None	2008–2012 Novo Nordisk Weight Watchers	2008–2012 None
		2013 None	2013 None	2013 None	2013 Aspire Bariatrics	2013 None
Catherine M. Loria, Ex-Officio	NHLBI—Nutritional Epidemiologist	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None
		2013 None	2013 None	2013 None	2013 None	2013 None
Barbara E. Millen	Boston Nutrition Foundation— Chairman; Millennium Prevention—President	2008–2012 None	2008–2012 None	2008–2012 Boston Nutrition Foundation* Millennium Prevention*	2008–2012 None	2008–2012 None
		2013 None	2013 None	2013 Boston Nutrition Foundation* Millennium Prevention*	2013 None	2013 None
Cathy A. Nonas	NYC Dept of Health and Mental Hygiene—Senior Advisor, Bureau for Chronic Disease Prevention and Tobacco Control	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None
		2013 None	2013 None	2013 None	2013 None	2013 None
F. Xavier Pi-Sunyer	Columbia University—Professor of Medicine, College of Physicians and Surgeons	2008–2012 Amylin AstraZeneca Eisai Eli Lilly McNeil Novo Nordisk Weight Watchers Zafgen	2008–2012 None	2008–2012 None	2008–2012 Arena Pharmaceuticals Novo Nordisk Orexigen Roche Vivus	2008–2012 None
		2013 AstraZeneca Eisai McNeil Novo Nordisk Vivus Weight Watchers Zafgen	2013 None	2013 None	2013 Novo Nordisk	2013 None
June Stevens	University of North Carolina at Chapel Hill—Chair, Department of Nutrition; Department of Epidemiology Schools of Public Health and Medicine—Professor	2008–2012 CMeducation Resources	2008–2012 None	2008–2012 None	2008–2012 Dannon PepsiCo, Gatorade Sanofi-aventis Wyeth Nutrition	2008–2012 None
		2013 None	2013 None	2013 None	2013 PepsiCo, Gatorade Sanofi-aventis Wyeth Nutrition	2013 None
Victor J. Stevens	Kaiser Permanente Center for HealthResearch—Assistant Director, Epidemiology and Disease Prevention	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None
		2013 None	2013 None	2013 None	2013 None	2013 None
Thomas A. Wadden	Perelman School of Medicine at the University of Pennsylvania—Professor of Psychology in Psychiatry; Center for Weight and Eating Disorders—Director	2008–2012 Alere Wellbeing BMIQ Novo Nordisk Orexigen Vivus	2008–2012 None	2008–2012 None	2008–2012 Novo Nordisk Nutrisystem Weight Watchers	2008–2012 None
		2013 Novo Nordisk Orexigen	2013 None	2013 None	2013 None	2013 None
Bruce M. Wolfe	Oregon Health and Science University—Professor of Surgery	2008–2012 Crospon EnteroMedics	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None
		2013 EnteroMedics	2013 None	2013 None	2013 None	2013 None
Susan Z. Yanovski, Ex-Officio	NIDDK—Co-Director, Office of Obesity Research, Division of Digestive Diseases and Nutrition	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None	2008–2012 None
		2013 None	2013 None	2013 None	2013 None	2013 None

This table reflects the relevant healthcare-related relationships of authors with industry and other entities provided by the Expert Panel during the document development process (2008–2012). Both compensated and uncompensated relationships are reported. These relationships were reviewed and updated in conjunction with all meetings and conference calls of the Expert Panel during the document development process. Authors with relevant relationships during the document development process recused themselves from voting on recommendations relevant to their relationships. In the spirit of full transparency, the ACC and AHA asked Expert Panel members to provide updates and approve the final version of this table, which includes current relevant relationships (2013). To review the NHLBI and ACC/AHA’s current comprehensive policies for managing relationships with industry and other entities, please refer to http://www.nhlbi.nih.gov/guidelines/cvd_adult/coi-rwi_policy.htm and http://www.cardiosource.org/Science-And-Quality/Practice-Guidelines-and-Quality-Standards/Relationships-With-Industry-Policy.aspx.

Per ACC/AHA policyv: A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$10 000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted.

^*Significant relationship.

^†No financial benefit.

ACC indicates American College of Cardiology; AHA, American Heart Association; NHLBI, National Heart, Lung, and Blood Institute; NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases; NIH, National Health Institute; PI, principal investigator; and TOS, The Obesity Society.